A Phase II Trial of Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma (BMS #CA225-331/Lilly Trial Alias I4E-US-X007)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 07 Apr 2017
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin; Cyclophosphamide; Doxorubicin
- Indications Malignant thymoma; Thymoma
- Focus Therapeutic Use
- 04 Apr 2017 Planned number of patients changed from 28 to 18.
- 04 Apr 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 04 Apr 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.